CEO David Rosa reported, "Q3 2025 was an excellent quarter for Intuitive, with strength in worldwide procedure growth and capital placements as well as increasing utilization across all platforms." He ...
VALPARAISO | The da Vinci robotic surgical platform n the technology that sparked a revolutionary change in prostate cancer surgery n is proving to be just as ...
A BREAKTHROUGH IN PROSTATE CANCER TREATMENT IS NOW AVAILABLE RIGHT HERE IN CINCINNATI, AND ONE LOCAL HOSPITAL AND DOCTOR ARE UTILIZING IT WITH EARLY SUCCESS. WLWT NEWS FIVE’S MEGAN MITCHELL SPOKE WITH ...
David J. Rosa, CEO, opened with recognition of Gary Guthart’s transition to Executive Chair, stating his excitement to lead Intuitive forward and emphasizing the company’s strong financial metrics for ...
Hosted on MSN
Intuitive Surgical outlines 13–15% da Vinci procedure growth for 2026 as global expansion accelerates
CEO David Rosa described 2025 as “a strong year for Intuitive, driven by multi-specialty da Vinci procedure growth across the globe, increasing adoption of da Vinci 5 and higher utilization across our ...
Intuitive Surgical (NASDAQ:ISRG) announced Wednesday that the U.S. Food and Drug Administration (FDA) greenlighted a label revision for its robotic surgical systems, da Vinci X and da Vinci Xi, to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results